On January 1, 2017, the Board of Directors of Nexeon MedSystems Inc. appointed Emily Hamilton, MD to serve as the Director of Emerging Therapy of the Company. Dr. Hamilton was the President of Rosellini Scientific LLC from 2010 to 2012 where she provided leadership to position the company at the forefront of the biomedical engineering industry. On January 1, 2017, the Board of Directors of the Company elected Kent J. George and Michael Neitzel as independent Directors of the Company. Mr. George has been associated with Robinson & McElwee PLLC, since 1987. Mr. George served as the Managing Member from 1999 through 2014 and has served as the Chief Executive Officer since 2014. Mr. Neitzel has been with DartPoints Holdings, LLC since January 2014 and currently serves as a Managing Partner.